R, P. (2024). Editorial: Extending upadacitinib induction dosing in ulcerative colitis-A delicate balance of efficacy and safety. Author's reply. Alimentary pharmacology & therapeutics, 59(4), 581. https://doi.org/10.1111/apt.17853
Chicago Style (17th ed.) CitationR, Panaccione. "Editorial: Extending Upadacitinib Induction Dosing in Ulcerative Colitis-A Delicate Balance of Efficacy and Safety. Author's Reply." Alimentary Pharmacology & Therapeutics 59, no. 4 (2024): 581. https://doi.org/10.1111/apt.17853.
MLA (9th ed.) CitationR, Panaccione. "Editorial: Extending Upadacitinib Induction Dosing in Ulcerative Colitis-A Delicate Balance of Efficacy and Safety. Author's Reply." Alimentary Pharmacology & Therapeutics, vol. 59, no. 4, 2024, p. 581, https://doi.org/10.1111/apt.17853.